| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 428.210.642 $ | 99,95 | 24.829.212 | ||||||
| Definium Therapeutics Inc | Definium Therapeutics Inc | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 13.233.152 $ | 3,09 | 281.317 | |
| MBX Biosciences Inc | MBX Biosciences Inc | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 11.645.102 $ | 2,72 | 210.962 | |
| Alumis Inc | Alumis Inc | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 9.171.220 $ | 2,14 | 325.914 | |
| AtaiBeckley Inc | AtaiBeckley Inc | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 9.114.855 $ | 2,13 | 1.729.574 | |
| Trevi Therapeutics Inc | Trevi Therapeutics Inc | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 9.099.204 $ | 2,12 | 487.893 | |
| Enliven Therapeutics Inc | Enliven Therapeutics Inc | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 8.967.322 $ | 2,09 | 176.696 | |
| Amylyx Pharmaceuticals Inc | Amylyx Pharmaceuticals Inc | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 8.723.549 $ | 2,04 | 485.721 | |
| VeraDermics Inc | VeraDermics Inc | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 8.643.911 $ | 2,02 | 70.310 | |
| Ligand Pharmaceuticals Inc | Ligand Pharmaceuticals Inc | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 8.323.914 $ | 1,94 | 26.334 | |
| Nuvation Bio Inc | Nuvation Bio Inc | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 8.107.990 $ | 1,89 | 1.427.463 | |
| Edgewise Therapeutics Inc | Edgewise Therapeutics Inc | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 8.068.834 $ | 1,88 | 198.593 | |
| Nektar Therapeutics | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 8.038.063 $ | 1,88 | 115.142 | |
| Liquidia Corp | Liquidia Corp | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 7.988.547 $ | 1,86 | 100.195 | |
| Maze Therapeutics Inc | Maze Therapeutics Inc | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 7.932.367 $ | 1,85 | 265.830 | |
| Harrow Inc | Harrow Inc | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 7.734.212 $ | 1,81 | 182.110 | |
| EyePoint Inc | EyePoint Inc | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 7.582.318 $ | 1,77 | 530.232 | |
| Amneal Pharmaceuticals Inc | Amneal Pharmaceuticals Inc | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 7.387.043 $ | 1,72 | 426.750 | |
| Ocular Therapeutix Inc | Ocular Therapeutix Inc | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 7.345.684 $ | 1,71 | 748.033 | |
| Corcept Therapeutics Inc | Corcept Therapeutics Inc | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 7.276.672 $ | 1,70 | 83.688 | |
| Crinetics Pharmaceuticals Inc | Crinetics Pharmaceuticals Inc | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 7.128.285 $ | 1,66 | 190.494 | |
| Pacira BioSciences Inc | Pacira BioSciences Inc | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 7.082.086 $ | 1,65 | 279.152 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 7.054.650 $ | 1,65 | 54.900 | |
| Indivior Pharmaceuticals Inc | Indivior Pharmaceuticals Inc | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 7.042.307 $ | 1,64 | 171.638 | |
| Elanco Animal Health Inc | Elanco Animal Health Inc | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 7.035.138 $ | 1,64 | 285.865 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 6.963.095 $ | 1,63 | 27.417 | |
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 6.905.119 $ | 1,61 | 5.757 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 6.861.139 $ | 1,60 | 28.473 | |
| Collegium Pharmaceutical Inc | Collegium Pharmaceutical Inc | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 6.800.749 $ | 1,59 | 187.866 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 6.775.305 $ | 1,58 | 117.586 | |
| Supernus Pharmaceuticals Inc | Supernus Pharmaceuticals Inc | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 6.743.903 $ | 1,57 | 144.999 | |
| Royalty Pharma PLC | Royalty Pharma PLC | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 6.723.634 $ | 1,57 | 119.915 | |
| Tarsus Pharmaceuticals Inc | Tarsus Pharmaceuticals Inc | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 6.716.264 $ | 1,57 | 106.709 | |
| WaVe Life Sciences Ltd | WaVe Life Sciences Ltd | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 6.711.079 $ | 1,57 | 1.155.091 | |
| Harmony Biosciences Holdings Inc | Harmony Biosciences Holdings Inc | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 6.709.089 $ | 1,57 | 184.265 | |
| Organon & Co | Organon & Co | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 6.615.996 $ | 1,54 | 488.626 | |
| ANI Pharmaceuticals Inc | ANI Pharmaceuticals Inc | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 6.612.549 $ | 1,54 | 79.881 | |
| Viatris Inc | Viatris Inc | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 6.583.372 $ | 1,54 | 414.570 | |
| Esperion Therapeutics Inc | Esperion Therapeutics Inc | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 6.579.445 $ | 1,54 | 2.082.103 | |
| Axsome Therapeutics Inc | Axsome Therapeutics Inc | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 6.496.441 $ | 1,52 | 26.541 | |
| Innoviva Inc | Innoviva Inc | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 6.455.431 $ | 1,51 | 284.255 | |
| BioAge Labs Inc | BioAge Labs Inc | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 6.425.370 $ | 1,50 | 262.153 | |
| Prestige Consumer Healthcare Inc | Prestige Consumer Healthcare Inc | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 6.290.219 $ | 1,47 | 133.070 | |
| Rapport Therapeutics Inc | Rapport Therapeutics Inc | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 6.161.076 $ | 1,44 | 147.854 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 6.149.671 $ | 1,44 | 255.385 | |
| Omeros Corp | Omeros Corp | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 6.095.530 $ | 1,42 | 640.960 | |
| Perrigo Co PLC | Perrigo Co PLC | EC | IE00BGH1M568 | Long | Börsenkurs (Stufe 1) | 6.081.298 $ | 1,42 | 585.303 | |
| Xeris Biopharma Holdings Inc | Xeris Biopharma Holdings Inc | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 5.966.191 $ | 1,39 | 753.307 | |
| Zoetis Inc | Zoetis Inc | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 5.779.556 $ | 1,35 | 80.428 | |
| Eton Pharmaceuticals Inc | Eton Pharmaceuticals Inc | EC | 29772L108 | Long | Börsenkurs (Stufe 1) | 5.590.511 $ | 1,30 | 154.434 | |
| Phibro Animal Health Corp | Phibro Animal Health Corp | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 5.501.563 $ | 1,28 | 175.209 | |
| Amphastar Pharmaceuticals Inc | Amphastar Pharmaceuticals Inc | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 5.360.232 $ | 1,25 | 265.621 | |
| Arvinas Inc | Arvinas Inc | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 5.342.732 $ | 1,25 | 642.928 | |
| Zevra Therapeutics Inc | Zevra Therapeutics Inc | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 5.296.866 $ | 1,24 | 369.377 | |
| Alto Neuroscience Inc | Alto Neuroscience Inc | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 5.019.457 $ | 1,17 | 190.203 | |
| Phathom Pharmaceuticals Inc | Phathom Pharmaceuticals Inc | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 4.554.678 $ | 1,06 | 419.786 | |
| Relmada Therapeutics Inc | Relmada Therapeutics Inc | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 4.533.029 $ | 1,06 | 655.062 | |
| CorMedix Inc | CorMedix Inc | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 4.315.969 $ | 1,01 | 549.805 | |
| Septerna Inc | Septerna Inc | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 4.243.049 $ | 0,99 | 126.696 | |
| Theravance Biopharma Inc | Theravance Biopharma Inc | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 4.098.649 $ | 0,96 | 241.097 | |
| Aclaris Therapeutics Inc | Aclaris Therapeutics Inc | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 3.829.685 $ | 0,89 | 723.948 | |
| LB Pharmaceuticals Inc | LB Pharmaceuticals Inc | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 3.413.325 $ | 0,80 | 105.171 | |
| Aquestive Therapeutics Inc | Aquestive Therapeutics Inc | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 3.276.628 $ | 0,76 | 787.651 | |
| Fulcrum Therapeutics Inc | Fulcrum Therapeutics Inc | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 2.955.768 $ | 0,69 | 807.587 | |
| Lexicon Pharmaceuticals Inc | Lexicon Pharmaceuticals Inc | EC | 528872302 | Long | Börsenkurs (Stufe 1) | 2.692.771 $ | 0,63 | 1.121.988 | |
| Evolus Inc | Evolus Inc | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 2.257.783 $ | 0,53 | 325.329 | |
| Gesamt | 428.210.642 $ | 99,95 | 24.829.212 |